
192.24 Delayed Data As of Feb 06 | ![]() Today’s Change | 92.26 Today|||52-Week Range 278.25 | -2.17% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $6.6B |
Karuna Therapeutics, Inc. 99 High Street Boston Massachusetts 02110 |
William J. Meury | President, Chief Executive Officer & Director |
Andrew Miller | Chief Operating Officer |
Troy A. Ignelzi | Chief Financial Officer & Secretary |
Stephen Brannan | Chief Medical Officer |
Steven Marc Paul | Director, Chief Scientific Officer, President-R&D |